» Articles » PMID: 21696598

Estimating and Modelling Cure in Population-based Cancer Studies Within the Framework of Flexible Parametric Survival Models

Overview
Publisher Biomed Central
Date 2011 Jun 24
PMID 21696598
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Background: When the mortality among a cancer patient group returns to the same level as in the general population, that is, the patients no longer experience excess mortality, the patients still alive are considered "statistically cured". Cure models can be used to estimate the cure proportion as well as the survival function of the "uncured". One limitation of parametric cure models is that the functional form of the survival of the "uncured" has to be specified. It can sometimes be hard to find a survival function flexible enough to fit the observed data, for example, when there is high excess hazard within a few months from diagnosis, which is common among older age groups. This has led to the exclusion of older age groups in population-based cancer studies using cure models.

Methods: Here we have extended the flexible parametric survival model to incorporate cure as a special case to estimate the cure proportion and the survival of the "uncured". Flexible parametric survival models use splines to model the underlying hazard function, and therefore no parametric distribution has to be specified.

Results: We have compared the fit from standard cure models to our flexible cure model, using data on colon cancer patients in Finland. This new method gives similar results to a standard cure model, when it is reliable, and better fit when the standard cure model gives biased estimates.

Conclusions: Cure models within the framework of flexible parametric models enables cure modelling when standard models give biased estimates. These flexible cure models enable inclusion of older age groups and can give stage-specific estimates, which is not always possible from parametric cure models.

Citing Articles

A Spline-Based Approach to Smoothly Constrain Hazard Ratios With a View to Apply Treatment Effect Waning.

Jennings A, Rutherford M, Lambert P Stat Med. 2025; 44(6):e70035.

PMID: 40059376 PMC: 11891414. DOI: 10.1002/sim.70035.


Analysis of temporal survival trends: considerations and best practice.

Simonsen M, Gjaerde L, Nielsen L, Valentin J, Waagepetersen R, El-Galaly T BMC Med Res Methodol. 2025; 25(1):51.

PMID: 39987028 PMC: 11847396. DOI: 10.1186/s12874-025-02505-5.


Estimating cure proportion in cancer clinical trials using flexible parametric cure models.

Sano Y, Tanaka S, Sato T BJC Rep. 2024; 2(1):61.

PMID: 39516583 PMC: 11524124. DOI: 10.1038/s44276-024-00092-4.


An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail?.

Latimer N, Taylor K, Hatswell A, Ho S, Okorogheye G, Chen C Pharmacoeconomics. 2024; 42(12):1395-1412.

PMID: 39302594 PMC: 11564353. DOI: 10.1007/s40273-024-01429-0.


General Population Mortality Adjustment in Survival Extrapolation of Cancer Trials: Exploring Plausibility and Implications for Cost-Effectiveness Analyses in HER2-Positive Breast Cancer in Sweden.

Kim K, Sweeting M, Wilking N, Jonsson L Med Decis Making. 2024; 44(7):843-853.

PMID: 39263806 PMC: 11491040. DOI: 10.1177/0272989X241275969.


References
1.
Dickman P, Adami H . Interpreting trends in cancer patient survival. J Intern Med. 2006; 260(2):103-17. DOI: 10.1111/j.1365-2796.2006.01677.x. View

2.
Tsodikov A . A proportional hazards model taking account of long-term survivors. Biometrics. 1999; 54(4):1508-16. View

3.
Nelson C, Lambert P, Squire I, Jones D . Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med. 2007; 26(30):5486-98. DOI: 10.1002/sim.3064. View

4.
Royston P, Parmar M . Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002; 21(15):2175-97. DOI: 10.1002/sim.1203. View

5.
Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G . The cure for colon cancer: results from the EUROCARE study. Int J Cancer. 1998; 77(3):322-9. DOI: 10.1002/(sici)1097-0215(19980729)77:3<322::aid-ijc2>3.0.co;2-q. View